Flputnam Investment Management Co. Purchases 3,047 Shares of Colgate-Palmolive (NYSE:CL)

Flputnam Investment Management Co. lifted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 168,367 shares of the company's stock after purchasing an additional 3,047 shares during the period. Flputnam Investment Management Co.'s holdings in Colgate-Palmolive were worth $15,306,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Swedbank AB raised its position in shares of Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company's stock valued at $306,246,000 after buying an additional 40,324 shares in the last quarter. Mutual Advisors LLC increased its stake in Colgate-Palmolive by 150.7% during the 3rd quarter. Mutual Advisors LLC now owns 15,367 shares of the company's stock worth $1,533,000 after acquiring an additional 9,238 shares during the period. Catalyst Financial Partners LLC raised its holdings in Colgate-Palmolive by 5.3% in the 3rd quarter. Catalyst Financial Partners LLC now owns 3,014 shares of the company's stock valued at $313,000 after acquiring an additional 152 shares in the last quarter. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $42,000. Finally, PineStone Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 0.3% during the 3rd quarter. PineStone Asset Management Inc. now owns 998,704 shares of the company's stock worth $103,675,000 after purchasing an additional 2,700 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 1.0 %

NYSE CL traded down $0.92 on Tuesday, hitting $91.89. The company's stock had a trading volume of 3,528,398 shares, compared to its average volume of 4,836,143. The firm has a market cap of $74.57 billion, a PE ratio of 26.11, a PEG ratio of 4.20 and a beta of 0.44. The company's 50-day moving average is $88.76 and its 200 day moving average is $95.37. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.18%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is presently 56.82%.

Analysts Set New Price Targets

A number of research analysts recently commented on CL shares. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.